• The future of the pharma-CRO relationship

    A new survey reveals the most important elements for a successful partnership between pharma and clinical research organisations

  • Thumbnail

    July/August issue out now!

    Featuring: The UK election and Pharma - Brexit and the EMA's relocation - The future of the Pharma-CRO relationship

  • Vote of confidence?

    Post-election jitters have struck pharma after a surprise result for the UK. With Brexit on the horizon and a minority government in charge, has the industry’s optimism been dashed?

  • Will there be a Brexit boom?

    With Brexit negotiations beginning, Catalyst Corporate Finance’s Tom Cowap argues that Britain's divorce from the EU could actually give a major boost to the UK’s pharma sector

  • The wearable revolution

    Wearables are here to stay – and pharma shouldn't ignore this golden opportunity

News

View all
Thumbnail image for US regulators wave through Pfizer’s leukaemia drug

US regulators wave through Pfizer’s leukaemia drug

The US Food and Drug Administration has approved Pfizer’s Besponsa, the first and only CD22-directed antibody-drug conjugate indicated to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).

18th August 2017

Thumbnail image for MHRA OK's psoriasis cream switch to OTC

MHRA OK's psoriasis cream switch to OTC

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved the switch of Dovonex Psoriasis Ointment from a prescription-only drug to one available in pharmacies

18th August 2017

Thumbnail image for Gov’t streams £5m into obesity research unit

Gov’t streams £5m into obesity research unit

The Department of Health has announced £5 million of funding for a new obesity policy research unit at University College London, alongside plans to cut calories in some foods to reign in the rising trend of childhood obesity.

18th August 2017

Thumbnail image for Global COPD deaths up 12 percent in 15 years

Global COPD deaths up 12 percent in 15 years

The number of people dying from chronic obstructive pulmonary disease has climbed nearly 12 percent over a 15-year period, an analysis for the Global Burden of Disease Study 2015 has found.

17th August 2017

Web Exclusives

View all
Thumbnail image for Harnessing predictive analytics

Harnessing predictive analytics

Joseph B. Laudano, vice president, medical affairs strategy for Medmeme, takes a look at advances in data mining and metrics analysis

Thumbnail image for Trust in the supply chain

Trust in the supply chain

In a world of increasingly complex pharma supply chains, technology is playing a growing role in helping smooth the relationship between businesses and their suppliers

Thumbnail image for Pregabalin: the battle continues

Pregabalin: the battle continues

A detailed look at the ongoing patent case for Pfizer’s pain drug and what the potentially-landmark ruling could mean for the industry

Thumbnail image for Will there be a Brexit boom?

Will there be a Brexit boom?

With Brexit negotiations beginning, Catalyst Corporate Finance’s Tom Cowap argues that Britain's divorce from the EU could actually give a major boost to the UK’s pharma sector

Thumbnail image for Vote of confidence?

Vote of confidence?

Post-election jitters have struck pharma after a surprise result for the UK. With Brexit on the horizon and a minority government in charge, has the industry’s optimism been dashed?

Thumbnail image for NHS-pharma partnerships

NHS-pharma partnerships

Improving the care of diabetes patients at City Hospitals Sunderland - a joint working initiative with Lilly

Thumbnail image for Sales 2.0

Sales 2.0

Engaging digital while retaining a human touch

Thumbnail image for Adapting to change

Adapting to change

Sanofi’s general manager for the UK and Ireland Hugo Fry on leading a company through transitional times

Thumbnail image for Realising potential

Realising potential

Richard Baderin, head of commercial enterprises at Accretio, on making the most of your resources

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download